Top Markets
#1 DogBull DogBull +49.01%
#2 Siren Siren +29.76%
#3 OriginTrail OriginTrail +21.49%
#4 MarsCoin MarsCoin +14.53%
#5 Verus Coin Verus Coin +7.09%
#6 Xphere Xphere +5.99%
#7 COTI COTI +5.94%
#8 PulseChain PulseChain +5.89%
#9 Concordium Concordium +5.86%
#10 Pons Pons +5.55%
Coin of the day
DogBull DogBull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
Pozycja w akcjach #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
Cena akcji
$0.46053443
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$92.44M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-36.86%
Kraj
CN
Handel Wuhan YZY Biopharma Co Ltd (2496)

Kategoria

Healthcare
Zyski dla Wuhan YZY Biopharma Co Ltd (2496)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Wuhan YZY Biopharma Co Ltd, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Wuhan YZY Biopharma Co Ltd od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH